Generated July 2026 from current fund data.
Overview
ARKK is an actively managed ETF investing in companies driving disruptive innovation across sectors like genomics, robotics, and artificial intelligence. OARK is a covered-call strategy ETF that holds ARKK shares and systematically sells call options against them to generate income. The key distinction: ARKK pursues capital appreciation through growth stock selection; OARK trades upside capture for high weekly income by writing options on the same underlying.
How they differ
ARKK and OARK track the same innovation theme but pursue opposite income-generation models. ARKK distributes annually and targets long-term capital growth with no option overlay; OARK wraps ARKK in a covered-call strategy, distributing 52.66% annually in weekly payments funded by option premium. This structural difference creates radically different return profiles: ARKK's 2.46 beta reflects growth-stock volatility with no downside cushion, while OARK's 1.66 beta suggests the call overlay caps upside but dampens drawdowns. OARK's 1.19% expense ratio exceeds ARKK's 0.75%, reflecting the cost of managing the derivatives program. OARK's AUM of $50.1M is roughly one-sixth of ARKK's $8.24B, signaling much thinner trading liquidity and a younger fund (inception November 2022 versus October 2014).
Who each is best for
ARKK: Fits investors with a multi-year horizon who seek exposure to high-growth disruptive companies and can tolerate above-market volatility in pursuit of capital appreciation, expecting to reinvest annual distributions.
OARK: Fits investors prioritizing weekly income stream and willing to accept capped upside and principal erosion over time in exchange for consistent option-premium generation, particularly those seeking to systematically reduce their exposure to the same growth theme.
Key risks to know
- NAV erosion at extreme distribution yields. A 52.66% annual payout rate on covered-call funds typically requires sustained high option premiums or return-of-capital treatment. As volatility contracts or ARKK's valuation tightens, premium income will likely decline, forcing OARK to pay out capital rather than earnings and eroding net asset value over time.
- Capped upside and opportunity cost. The covered-call structure caps gains when ARKK rallies sharply. Investors in OARK forfeit those gains; over bull-market periods, this mechanical drag can significantly underperform buy-and-hold ARKK holders.
- Options volatility risk and early assignment. If ARKK moves deeply in-the-money, OARK's short calls may be assigned early, forcing involuntary sales of shares at strike prices below current market value and crystallizing opportunity loss.
- Concentration and sector overlap. Both funds hold identical ARKK exposure, which is itself a concentrated bet on disruptive innovation. Sector drawdowns in genomics, robotics, or AI will hit both funds hard; holdings overlap is total.
- Liquidity and bid-ask risk. OARK's $50.1M AUM is substantially smaller than ARKK's, likely producing wider bid-ask spreads and slower order fills, especially in market stress when trading volume often evaporates.
Bottom line
ARKK is a pure-growth play with full upside capture and lower fees; OARK trades that upside for predictable weekly income via options, accepting NAV erosion risk and opportunity cost. If you prioritize long-term capital growth and can tolerate volatility, ARKK's simpler structure and larger fund size offer cleaner execution; if you want steady income and are comfortable capping gains, OARK's high distribution rate may appeal—but verify the sustainability of its payout by monitoring coverage ratios as volatility evolves. Past performance does not guarantee future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.
